Abstract
Substantial progress has been made in understanding the pathogenesis of malignant melanoma at the cellular level, leading to the development of several new agents in the treatment of melanoma. The focus of this review is to summarize the emerging therapies and investigational agents in the treatment of melanoma over the last 5 years.
Original language | English (US) |
---|---|
Pages (from-to) | 553-560 |
Number of pages | 8 |
Journal | Expert review of anticancer therapy |
Volume | 8 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2008 |
Keywords
- Angiogenesis inhibitors
- Chemotherapy
- Emerging therapies
- Immunotherapy
- Melanoma
- Targeted therapies
ASJC Scopus subject areas
- Oncology
- Pharmacology (medical)